views
Influenza is simply referred to as the flu. It
is an infectious disease of the upper respiratory tract caused by the influenza
virus. The seasonal influenza virus is classified into three types: Influenza
B, Influenza A, And Influenza C, which are characterized by two major surface
proteins: hemagglutinin (HA) and neuraminidase (NA). Different serotypes are
observed as a result of differences in these surface proteins, which determine
the antibody response to the viruses. Because influenza is a highly contagious
and communicable disease, infected patients who serve as carriers of the
disease can easily transmit the disease in public places.
The disease
burden varies by region, with temperate climate regions experiencing seasonal
influenza outbreaks. In tropical regions where influenza occurs all year,
causing constant outbreaks, disease management and treatment are difficult.
Rising demand for rapid disease diagnosis, rising influenza prevalence, and
increased influenza research for diagnostic technologies are driving the Influenza Diagnostics Market growth.
Global
Influenza Diagnostics Market Size, Share & Industry Analysis, Report [2030]
Competitive Landscape
The Global Influenza
Diagnostics Market is segmented based on Test Type, End-User, and Region. Based
on Test Type it is categorized into Traditional Diagnostic Test and Molecular
Diagnostic Assay. The Traditional Diagnostic Test segment is further bifurcated
into RIDT, Viral Culture, Direct Fluorescent Antibody (DFA) Test, and
Serological Assay. Molecular Diagnostic Assay is sub-segmented into RT-PCR,
Nucleic Acid Sequence-based Amplification (NASBA) Test, Loop-mediated
Isothermal Amplification-based Assay (LAMP), Simple Amplification-based Assay
(SAMBA), and Other Molecular Diagnostic Assays. By End User, the Influenza
Diagnostics Market studied is segmented into hospitals, Laboratories, and Other
End Users. Based on the region it is categorized into North America, Europe,
Asia-Pacific, South America, and MEA.
Influenza
Diagnostics Market Analysis by Test Type
In 2022, the rapid influenza
diagnostic test (RIDT) is anticipated to hold the largest market share in the
test type segment of the influenza diagnostics market, out of all traditional
diagnostic tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays
that detect and provide qualitative results for influenza A and B viral
nucleoprotein antigens in respiratory specimens. It is capable of diagnosing
patients with influenza-like illness, particularly if performed within the
first four days of symptoms appearing. RIDT's popularity is driven by the
benefits of faster results and ease of use. Some RIDTs are also approved for
use in the office or at the patient's bedside. The RIDT segment is also
expected to grow rapidly due to its widespread use in point-of-care settings.
Influenza
Diagnostics Market Analysis by End-user
The diagnostic
laboratories segment dominated the influenza diagnostics market in 2021. The
rising prevalence of influenza, as well as the growing demand for rapid disease
diagnosis, are driving the growth of this segment
Read more: https://www.skyquestt.com/report/influenza-diagnostics-market
Comments
0 comment